 ROCKVILLE, Md.--BUSINESS WIRE--GlycoMimetics, Inc. Nasdaq: GLYC, today announces that Chief Executive Officer Rachel King will provide a company overview at the Jefferies 2021 Virtual Healthcare Conference. Ms. Kings presentation will take place from 2:30 to 2:55 p.m. on June 3, 2021. More information is available in the Investors section of the GlycoMimetics website. About GlycoMimetics, Inc. GlycoMimetics is a clinical-stage biotechnology company discovering and developing glycobiology-b 